Changes in levels of cortical metabotropic glutamate 2 receptors with gender and suicide but not psychiatric diagnoses
Brian Dean, Clare Duncan, Andrew Gibbons
JOURNAL OF AFFECTIVE DISORDERS | ELSEVIER SCIENCE BV | Published : 2019
BACKGROUND: We previously reported that, compared to controls, there are lower levels of [3H]LY341495 binding to metabotropic 2/3 receptors (GRM2/3) in Brodmann's area (BA) 24, but not 17 or 46, from subjects with major depressive disorders (MDD) but not bipolar disorders (BD) or schizophrenia. To be able to better interpret these data we have now measured levels of GRM2 in two of these cortical regions. METHODS: Using a rabbit anti-metabotropic GRM2 monoclonal antibody with Western blotting we measured levels of GRM2 in BA 24 and 46 from subjects with MDD, BD, schizophrenia and controls (n = 15 per group). RESULTS: Compared to controls, levels of GRM2, normalised to β-actin, did not differ ..View full abstract
Awarded by National Medical & Health Research Council
This work was supported by the National Medical & Health Research Council (grant numbers 1025774, 566967, 1002240), the CRC for Mental Health, One in Five and the Andrew and Claire Heenan Ride for Ben as well as Operational Infrastructure Support from the Victorian State Government. None of the funding bodies had any influence over the research activity that produced the data reported.